Table 1 |
|
Homocysteine lowering intervention trials for the prevention of CVD. |
| 1. SEARCH: Study of the effectiveness of additional reduction in cholesterol and homocysteine.
University of Oxford, England. |
| 2. PACIFIC: Prevention with a combined inhibitor of folate in coronary heart disease. University
of Sydney, Australia. |
| 3. WACS: Women's antioxidant and cardiovascular disease study. Harvard Medical School, USA. |
| 4. CHAOS-2: Cambridge heart antioxidant study. University of Cambridge, England. |
| 5. NORVITE: Norwegian study of homocysteine lowering with B-vitamins in myocardial infarction.
University of Tromso, Norway. |
| 6. BERGEN: Bergen vitamin study. University of Bergen, Norway. |
| 7. HOPE-2: Health outcome and prevention evaluation number 2. Canada. |
| 8. VISP: Vitamin intervention for stroke prevention. Wake Forest University, USA. |
| 9. VITATOPS: Vitamins to prevent strokes. Perth, Australia. |
| 10. IST-2: International strokes trial number 2. Auckland, New Zealand. |
|
|
|
Hayden and Tyagi Nutrition Journal 2004 3:4 doi:10.1186/1475-2891-3-4 |
